Clinical Director, Assistant Professor of Medicine
Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School
Boston, Massachusetts
Dr. Jacob Laubach, MD is an Assistant Professor in Medicine at Harvard Medical School and the Clinical Director of the Jerome Lipper Multiple Myeloma Center at Dana Farber Cancer Institute. Dr. Laubach completed his medical degree, residency and fellowship in hematology at Duke University Medical Center. He joined the Dana Farber Cancer Institute faculty in 2008.
Since joining the Dana Farber Cancer Institute faculty in 2008, he has developed a large academic practice focused on the care of patients with plasma cell disorders, including multiple myeloma, AL amyloidosis, and other plasma cell disorders. As a clinical investigator, Dr. Laubach has been integrally involved in the study of histone deacetylase inhibition as a treatment strategy and in the development of monoclonal antibodies such as Elotuzumab and Daratumumab.
Disclosure information not submitted.
Friday, March 25, 2022
10:45 AM – 11:50 AM
Friday, March 25, 2022
11:10 AM – 11:30 AM
Friday, March 25, 2022
11:30 AM – 11:50 AM
Friday, May 13, 2022
12:10 PM – 1:45 PM
Friday, May 13, 2022
12:15 PM – 12:35 PM
Friday, May 13, 2022
1:25 PM – 1:45 PM